Based on a study conducted by the centre, about 27 per cent of voters in Sabah are fence-sitters, and their choices would depend more on the chance of a believable future, and not loyalty to any ...

The training centered on the AT32F457 development board, combining "theory explanation × hands-on practice" through a ...

Total Revenue -- $86,000 was recognized in the third quarter from initial sales of nPulse Capital and Vibrance disposables ...

Okay, but what is vibe coding, really? Stop nodding and smiling every time you hear this phrase and get started with AI vibe ...

Syncfusion®, Inc., the enterprise technology provider of choice, today announced the launch of Code Studio, an integrated development environment (IDE) that brings code generation, editing, and ...

The Company continues to prioritize securing FDA Investigational Device Exemption (IDE) approval to initiate human clinical studies at Mayo Clinic. Over the past several years, Vivos has successfully ...

Microsoft’s November Visual Studio roadmap highlights new AI agents, GPT-5 Codex integration, and improved MCP governance.

Get the latest on Pulse Biosciences’ Q3 2025 earnings: commercial growth, FDA progress, and clinical trial updates in soft tissue and cardiac therapies.

To access the live conference call, participants may register here. The live audio webcast of the call will be available under "Events and Presentations" in the Investor Relations section of the Atea ...

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

The IDE approval marks a pivotal milestone for Aqua Medical, allowing the company to begin enrolling patients in the U.S. RESTORE-1 pilot trial and study PIMA's potential to deliver durable metabolic ...

DISP-10 is a novel tumor-specific virus and CAR T combination designed to overcome key challenges of applying CAR T therapy to solid tumors DISP-10 has broad potential to target all solid tumors of ...